Down regulation of miR-143 is related with tumor size, lymph node metastasis and HPV16 infection in cervical squamous cancer

Diagnostic Pathology

Volumn 9, Issue 1, 2014, Pages

  Chen, Yanxia ^a   Ma, Cailing ^a   Zhang, Wei ^a   Chen, Zhifang ^a   Ma, Li ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MICRORNA; MIRN143 MICRORNA, HUMAN; PACLITAXEL; TUMOR MARKER; VIRUS DNA;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHI SQUARE DISTRIBUTION; CHINA; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; ISOLATION AND PURIFICATION; LYMPH NODE METASTASIS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SECONDARY; TREATMENT OUTCOME; TUMOR VOLUME; UTERINE CERVICAL NEOPLASMS; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; CHINA; DNA, VIRAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; LYMPHATIC METASTASIS; MICRORNAS; MIDDLE AGED; NEOADJUVANT THERAPY; PACLITAXEL; PAPILLOMAVIRUS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84901650541     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-9-88     Document Type: Article

References (38)

1. Qian X, Yu J, Yin Y, He J, Wang L, Li Q, Zhang LQ, Li CY, Shi ZM, Xu Q, Li W, Lai LH, Liu LZ, Jiang BH. MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers. Cell Cycle 2013, 12:1385-1394. 10.4161/cc.24477, 23574723.
2. Wald AI, Hoskins EE, Wells SI, Ferris RL, Khan SA. Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus. Head Neck 2011, 33:504-512. 10.1002/hed.21475, 3080748, 20652977.
3. Lajer CB, Garnæs E, Friis-Hansen L, Norrild B, Therkildsen MH, Glud M, Rossing M, Lajer H, Svane D, Skotte L, Specht L, Buchwald C, Nielsen FC. The role of miRNAs in human papilloma virus (HPV)-associatedcancers: bridging between HPV-related head and neck cancer and cervical cancer. Br J Cancer 2012, 106:1526-1534. 10.1038/bjc.2012.109, 3341860, 22472886.
4. Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, Zheng ZM. Aberrant Expression of Oncogenic and TumorSuppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth. PLoS One 2008, 7:e2557.
5. Deftereos G, Corrie SR, Feng Q, Morihara J, Stern J, Hawes SE, Kiviat NB. Expression of Mir-21 and Mir-143 in Cervical SpecimensRanging from Histologically Normal through to Invasive Cervical Cancer. PLoS One 2011, 6:e28423. 10.1371/journal.pone.0028423, 3237431, 22194833.
6. Yamakawa Y, Fujimura M, Hidaka T, Hori S, Saito S. Neoadjuvant Intraarterial Infusion Chemotherapy in Patients with Stage IB2-IIIB Cervical Cancer. Gynecol Oncol 2000, 77:264-270. 10.1006/gyno.2000.5730, 10785476.
7. Zhang JX, Song W, Chen ZH, Wei JH, Liao YJ, Lei J, Hu M, Chen GZ, Liao B, Lu J, Zhao HW, Chen W, He YL, Wang HY, Xie D, Luo JH. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Lancet Oncol 2013, 14:1295-1306. 10.1016/S1470-2045(13)70491-1, 24239208.
8. Borralho PM, Kren BT, Castro RE, da Silva IB, Steer CJ, Rodrigues CM. MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. FEBS J 2009, 276:6689-6700. 10.1111/j.1742-4658.2009.07383.x, 19843160.
9. Xu B, Niu X, Zhang X, Tao J, Wu D, Wang Z, Li P, Zhang W, Wu H, Feng N, Wang Z, Hua L, Wang X. miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS. Mol Cell Biochem 2011, 350:207-213. 10.1007/s11010-010-0700-6, 21197560.
10. Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, Labourier E, Hahn SA. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007, 26:4442-4452. 10.1038/sj.onc.1210228, 17237814.
11. Akagi I, Miyashita M, Ishibashi O, Mishima T, Kikuchi K, Makino H, Nomura T, Hagiwara N, Uchida E, Takizawa T. Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma. Dis Esophagus 2011, 24:523-530. 10.1111/j.1442-2050.2011.01177.x, 21453382.
12. Zhang X, Liu S, Hu T, Liu S, He Y, Sun S. Up -regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 2009, 50:490-499. 10.1002/hep.23008, 19472311.
13. Fan X, Chen X, Deng W, Zhong G, Cai Q, Lin T. Up-regulated microRNA-143 in cancer stem cells differentiation promotes prostate cancer cells metastasis by modulating FNDC3B expression. BMC Cancer 2013, 13:1-11. 10.1186/1471-2407-13-1, 3545739, 23282137.
14. Ni Y, Meng L, Wang L, Dong W, Shen H, Wang G, Liu Q, Du J. MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma. Gene 2013, 517:197-204. 10.1016/j.gene.2012.12.031, 23276710.
15. Lin T, Dong W, Huang J, Pan Q, Fan X, Zhang C, Huang L. MicroRNA-143 as a tumor suppressor for bladder cancer. J Urol 2009, 181:1372-1380. 10.1016/j.juro.2008.10.149, 19157460.
16. Clapé C, Fritz V, Henriquet C, Apparailly F, Fernandez PL, Iborra F, Avancès C, Villalba M, Culine S, Fajas L. miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PLoS One 2009, 4:e7542. 10.1371/journal.pone.0007542, 2763222, 19855844.
17. Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y, Cai X, Wang K, Wang G, Ba Y, Zhu L, Wang J, Yang R, Zhang Y, Ren Z, Zen K, Zhang J, Zhang CY. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 2009, 28:1385-1392. 10.1038/onc.2008.474, 19137007.
18. Zhang Y, Wang Z, Chen M, Peng L, Wang X, Ma Q, Ma F, Jiang B. MicroRNA-143 Targets MACC1 to Inhibit Cell Invasion and Migration in Colorectal cancer. Mol Cancer 2012, 11:1-9. 10.1186/1476-4598-11-1, 3281783, 22216762.
19. Zhang H, Cai X, Wang Y, Tang H, Tong D, Ji F. microRNA-143 down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol Rep 2010, 24:1363-1369.
20. Akao Y, Nakagawa Y, Iio A, Naoe T. Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells. Leuk Res 2009, 33:1530-1538. 10.1016/j.leukres.2009.04.019, 19464056.
21. Noguchi S, Yasui Y, Iwasaki J, Kumazaki M, Yamada N, Naito S, Akao Y. Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways. Cancer Lett 2013, 28:353-361.
22. Wang XF, Shi ZM, Wang XR, Cao L, Wang YY, Zhang JX, Yin Y, Luo H, Kang CS, Liu N, Jiang T, You YP. MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2. J Cancer Res Clin Oncol 2012, 138:573-584. 10.1007/s00432-011-1114-x, 22207524.
23. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, Hong L, Liu J, Fan D. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 2008, 123:372-379. 10.1002/ijc.23501, 18449891.
24. Lui WO, Pourmand N, Patterson BK, Fire A. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 2007, 67:6031-6043. 10.1158/0008-5472.CAN-06-0561, 17616659.
25. Liu L, Yu X, Guo X, Tian Z, Su M, Long Y, Huang C, Zhou F, Liu M, Wu X, Wang X. miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2. Mol Med Rep 2012, 5:753-760.
26. Liu R, Liao J, Yang M, Sheng J, Yang H, Wang Y, Pan E, Guo W, Pu Y, Kim SJ, Yin L. The Cluster of miR-143 and miR-145 Affects the Risk for Esophageal Squamous Cell Carcinoma through Co-Regulating Fascin Homolog 1. PLoS One 2012, 7:e33987. 10.1371/journal.pone.0033987, 3311581, 22457808.
27. Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M, Nenutil R, Vyzula R. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 2007, 72:397-402. 10.1159/000113489, 18196926.
28. Ivanov S, Zervoudis S, Ivanov S. Metastatic cancer in transposed ovaries after radical Wertheim-Meigs hysterectomy for a stage I B and II A cervical cancer. Akush Ginekol (Sofiia) 2003, 42:22-24.
29. Munoz N, Bosch FX, Sanjose S. Epidemiologic classification of human papillomavirus type associated with cervical cancer. N Engl J Med 2003, 348:518-527. 10.1056/NEJMoa021641, 12571259.
30. Nambaru L, Meenakumari B, Swaminathan R, Rajkumar T. Prognostic significance of HPV physical status status and integration sites in cervical cancer. Asian Pac J Cancer Prev 2009, 10:355-360.
31. Boominathan L. The Tumor Suppressors P53, P63, and P73 are Regulators of MicroRNA Processing Complex. PLoS One 2010, 5:e10615. 10.1371/journal.pone.0010615, 2868896, 20485546.
32. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, Khan SA. Human papillomavirus type16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 2008, 27:2575-2582. 10.1038/sj.onc.1210919, 2447163, 17998940.
33. Lai VK, Ashraf M, Jiang S, Haider K. MicroRNA-143 is a critical regulator of cell cycle activity in stem cells with co-overexpression of Akt and angiopoietin-1 via transcriptional regulation of Erk5/cyclin D1 signaling. Cell Cycle 2012, 11:767-777. 10.4161/cc.11.4.19211, 3318108, 22374674.
34. Ryan JJ, Prochownik E, Gottlieb CA, Apel IJ, Merino R, Nuñez G, Clarke MF. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci U S A 1994, 91:5878-5882. 10.1073/pnas.91.13.5878, 44100, 8016082.
35. Liu H, Liu S, Wang H, Xie X, Chen X, Zhang X, Zhang Y. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer. Diagn Pathol 2012, 7:147. 10.1186/1746-1596-7-147, 3488518, 23107094.
36. Chen S, Yang Z, Zhang Y, Qiao Y, Cui B, Zhang Y, Kong B. Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia. Diagn Pathol 2012, 7:40. 10.1186/1746-1596-7-40, 3379933, 22500694.
37. Han H, Yang Y, Lu Z, He Q, Lin Z. Decreased D2-40 and increased p16INK4A immunoreactivities correlate with higher grade of cervical intraepithelial neoplasia. Diagn Pathol 2011, 6:59. 10.1186/1746-1596-6-59, 3157410, 21729305.
38. Imura J, Uchida Y, Nomoto K, Ichikawa K, Tomita S, Iijima T, Fujimori T. Laminin-5 is a biomarker of invasiveness in cervical adenocarcinoma. Diagn Pathol 2012, 7:105. 10.1186/1746-1596-7-105, 3520835, 22898004.